Drug repurposing and therapeutic anti-mirna predictions in oxldl-induced the proliferation of vascular smooth muscle cell associated diseases
|
|
- Gary Briggs
- 6 years ago
- Views:
Transcription
1 Drug repurposing and therapeutic anti-mirna predictions in oxldl-induced the proliferation of vascular smooth muscle cell associated diseases Shun-Tsung Chen, Chien-Hung Huang, Victor C. Kok, Chi-Ying F Huang, Jin-Shuei Ciou, Jeffrey J. P. Tsai, Nilubon Kurubanjerdjit and Ka-Lok Ng * * Department of Bioinformatics & Medical Engineering Asia University, Taiwan
2 Contents, 1. Introduction human cardiovascular disease (CVD), drug repurposing, Connectivity Map (cmap), antimir 2. Methods - The ebayes algorithms for identifying DEGs, ClusterONE, cmap, DAVID, DrugBank, NCBI, mirtarbase and TarBase resources for identifying potential drugs and therapeutic antimir 3. Results - supported by the literature, in-vitro IC 50 and clinical trials 4. Discussion - obtained certain successive results, there are still some deficiencies or limits 5. Conclusions - drug-finding pipeline is effective for drug repurposing and therapeutic antimir discovery 2
3 Introduction Ø Cardiovascular disease (CVD) is the most important cause of morbidity and mortality worldwide. According to the World Health Organization (WHO) report, CVD affects tens of millions of human beings each year. Therefore, how to improve the diagnosis, treatment and prevention of CVD is an urgent and important issue. Ø The vessel is subjected to oxidized low-density lipoprotein (oxldl) initiate signaling pathways, then trigger differential gene expression, next induce vascular smooth muscle cell (VSMC) dedifferentiation results in VSMC phenotypic transition VSMC phenotypic transition is the major cause of ATs, restenosis and hypertension. 3
4 Blood artery and cellular structure VSMC 4
5 VSMC proliferation-associated diseases Heart and blood artery 5
6 Atherosclerosis (ATs) and VSMC 6
7 Hypothesis ~ ATs and cancer formation Ø Studies have suggested that ATs and cancer formation involve similar cellular processes: proliferation, inflammation and genomic instability. Ø Both types of diseases possess common pathways or signal transduction networks, such as PI3k/Akt, can mediate several functional and morphological alterations of VSMC after being activated to develop vascular diseases, as well as affect the growth, apoptosis and cell cycle regulation of various cell types to induce cancer progression. Ø It is also known that the MAPK pathway, involved in VSMC proliferation, hypertrophy, and migration, The concept of similar therapeutic strategies and drugs is proposed to target both conditions via identifying potential drugs. 7
8 From disease to drug discovery The main objective of biomedical research is to connect human diseases with the genetic elements and identify drugs that treat them Nature Reviews Cancer 7(1), (2007)
9 Traditional drug discovery process Reference : 9
10 Drug repurposing Ø It is a recently developed approach that endeavors to identify new uses for existing drugs and has achieved certain successes. Ø It has the potential to accelerate the development and bring down the exploitation costs for drugs, as well as reducing side effects. Ø The drug-gene interaction database, cmap, is used to find potential drugs for treating the proliferation of VSMC associated diseases.
11 cmap Using Gene Expression Signatures to connect Drugs, Genes, and Diseases. Nature Reviews Cancer 7(1), (2007) Science 313(5795), (2006)
12 cmap (continued) Ø The cmap is a robust tool to address questions in different cells. four cell line experiments, i.e. MCF7, PC3, HeL60 and SKMEL5 dosage ( ~ 2 to 20 micro-molar), duration ( ~ 6 hours) Ø This diversity of cell types provides an opportunity to assess the extent to which results are context dependent. Ø Even though it is impossible to meet all conditions, results from different cell lines are in general acceptable to most of the users.
13 Search for the proliferation of VSMC associated diseases drugs Negative signature Disease query Normal Hypothesis If a drug signature could reverse, at least in part, the gene expression signature of disease, this drug might have the potential to inhibit disease pathways and thereby treat VSMC proliferation-associated diseases.
14 Central dogma of molecular biology mirna & antimir (suppress mirna) 14
15 mirna & antimir Ø MiRNAs may modulate gene expression and protein synthesis through negatively regulating. regulate many biological processes (BPs), such as cell development, differentiation, signaling, metabolism and etc. Ø MiR-21, 143/145 and 221/222 actively involved in regulation of VSMC Ø MiR-145 has an anti-proliferative effect when over-expressed. 15
16 mirna & antimir (continued) The above results indicated mirnas play a key role in the regulation of the VSMC phenotype transition and causing VSMC associated diseases. as biomarkers in the proliferation of VSMC associated diseases diagnosis and prevention development of mirna-based therapeutic treatments, through using antimirs to inhibit mirna expression Ø MiRNA-based therapy (gene therapy) FDA (the treatment of hyperlipidemia) 16
17 mirna & antimir (continued) Ø AntimiR mediated pharmacological inhibition of disease-associated mirnas, shows great promise in the development of novel mirnabased therapeutics. Ø three in vivo studies suggested that the inhibition of mir-33 by antimir- 33 raise HDL cholesterol levels reverse cholesterol transport and regresses ATs antimir-based mirna therapeutics could be a useful strategy for treating the proliferation of VSMC associated diseases 17
18 Microarray data analysis Ø The microarray experiment enables us to filter differentially expressed genes (DEGs) Ø Microarray data analysis resource, Bioconductor, was used to identify DEGs. Ø DEGs were divided into two groups ~ up-regulated and down-regulated 18
19 The treatment concept of oxldl-induced the proliferation of VSMC associated diseases Fig. 1. The concept of treatment for oxldl-induced VSMC associated diseases. Up and down denote the up- and down-regulated DEGs, respectively. The dotted line denotes the interactive relationships among antimir, mirna and down-regulated DEGs. The arrows and the blunts denote activation and suppression respectively. 19
20 Methods - workflow of this study Drug repurposing and therapeutic anti-mirna predictions (oxldlinduced the proliferation of VSMC associated diseases): (1) DEGs identification, (2) ClusterONE analysis, (3) GO enrichment analysis, (4) KS-test, (5) drug repurposing and effectiveness verification (IC50), (6) drug target, mirnas and antimirs identification 20
21 MTT cell viability test & Clonogenic assay Ø MTT cell viability test To determine the effective cytotoxicity of screening drugs, MTT assay was used for cell viability and proliferation. In general, all incubated NSCLC cell lines (A549 and H460) were seeded in a 96-well microplate for up to 24 hrs dependent on the baseline growth rate. Ø Clonogenic assay We use two different high clonogenic lung cancer cell lines, A549 and H460 to perform the clonogenic assay. 21
22 Datasets Ø NCBI GEO microarray experiment, GSE made use of human aortic samples with gene expression measured at five different time course of 0, 2, 6, 12 and 24 hours. Ø Each time point measurement was repeated twice to examine the temporal patterns of the gene expression in response to oxldl. 22
23 Identification of DEGs Ø Microarray data analysis resource, Bioconductor, was adopted in this study. Ø ebayes algorithm, an intrinsic function of the limma package, computes moderated t-statistics of differential expression by ebayes shrinkage of the standard errors towards a common value. moderated t-statistics is defined by 23
24 Identification of DEGs (continued) Ø ebayes is adopted for identifying top ranked DEGs. DEGs with an adjusted p-values < 5% Ø up- and down-regulated DEGs were employed for searching anti-correlated drug-induced signatures a drug found inthe cmapmayreverse the disease signature if the drug-induced gene expression profile is significantly negative correlated with the disease-induced gene expression profile. Ø up- or down-regulated DEGs whose expressions must satisfy below condition: Consecutively up- or down-regulated in the four time intervals, i.e. 0~2, 2~6, 6~12 and 12~24 hr. 24
25 ClusterONE analysis Ø To improve the drug prediction accuracy according to IC50 measurements. ClusterONE, clustering with overlapping neighborhood expansion, is applied for generating clusters. Ø Protein-protein interaction (PPI) information from BioGRID, ClusterONE identify both the up- and down-regulated clusters. 25
26 Gene Ontology (GO) enrichment analysis Ø Functional annotation of the DEGs is given by DAVID One can obtain the most relevant BPs and pathways terms associated with a given gene list. Ø The list of VSMC DEGs was submitted to DAVID enriched BPs and KEGG pathways were obtained 26
27 Kolmogorov Smirnov test (KS-test) Ø The KS-test seeks differences between two datasets, and it is non-parametric and distribution free. Ø It is conjectured that the set of consecutively up- and down-regulated DEGs may tend to cluster among the top-ranked DEGs. we performed the KS-test for testing if this conjecture issignificant or not. 27
28 Drug repurposing Ø It has the potential to accelerate the development and bring down the exploitation costs for drugs, as well as reducing side effects. Ø Using cmap to find potential drugs for treating the proliferation of VSMC associated diseases. Using both up- and down-regulated DEG sets to query the cmap database. Potential drugs with p-values < 0.05, both enrichment scores and connective scores < 0. Potential drugs are supported by cell viability (the IC50 values) 28
29 Identify drug targets, mirnas and antimirs Ø Over-expressed mirnas may down-regulated certain genes VSMC phenotype transition Ø Certain drugs may target down-regulated DEGs and reverse their expression level. Drug-targeted are obtained by submitting the potential drugs to both DrugBank and PubChem MiRNA targeted gene data are obtained from mirtarbase and TarBase. Ø Identify antimirs that could hybridize the group of mirnas which targeted down-regulated DEGs for inhibiting aberrant mirna expression. 29
30 Results DEGs and their related functional terms Ø Obtained 7,245 DEGs, 86 of them are relevant for the formation of CVDs, 48 of them are associated with the proliferation of VSMC associated diseases Ø A website provides the following information: (i) gene list information (SABiosciences and literature review), and (ii) the 48 DEGs with their supporting references, see Ø Table 1 listed these 48 genes with certain functional terms. 30
31 31
32 Results Gene Ontology (GO) enrichment analysis Ø DAVID can only process a limited number of input genes. 1. top 3,000 DEGs (adjusted p-values < 5.48e-03) up- and 452 down-regulated genes 7, up- and 278 down-regulated genes top 3,000 1~3 were submitted to DAVID, enriched BPand pathway-related terms were obtained. BP or pathways with a p-value < 0.05 are kept. Ø Top two clusters of BPs and pathways information can be found in 32
33 Results GO enrichment analysis (continued) Ø Results show: 1. Enriched BPs or pathways are associated with cancer- or cell regulation-related events. 2. Many DEGs involved in the proliferation of VSMC associated diseases or cancer. 33
34 Results Kolmogorov-Smirnov (KS) test Ø Table 2 shows the percentages of the set of up- and down-regulated DEGs. Ø KS-test: p-value = D is 0.4 does not suggest that the consecutively up- and down-regulated DEGs tends to cluster in top-ranked DEGs 34
35 Results KS-test (continued) Fig. 4. The comparison plots of the KS-test: (a) KS-test comparison percentile plot (b) KS-test comparison cumulative fraction plot. Dotted lines denote the up- and down-regulated DEGs, and solid lines denote the not upand down-regulated DEGs. 35
36 Results Potential repurposed drugs Ø 298 and 322 up- and down-regulated DEGs were analyzed 37 drugs were identified and their information were presented in Table 3 GW-8510, 8-azaguanine and camptothecin (8.1%) have determined IC50 activities none of above three drugs are under clinical trials there are ten drugs (27%) which are under clinical trials for CVD-associated diseases (Table 4). Ø Identified drugs are potential repurposed drugs for inhibiting VSMC proliferation-associated diseases. 36
37 37
38 Results Drugs derived from ClusterONE Ø One up-regulated cluster with 3 genes (p-value < 0.03) and three down-regulated clusters with 6 genes (p-value < 0.002), 3 genes (< 0.03) and 3 genes ( < 0.08) were combined for further analysis. Ø Three combinations, the up-regulated cluster with ~ the down-regulated cluster with p-value < 0.03 IC50 measurement hit ratio is 22.2% (8/36). ~ the cluster with p-value < 0.08 the hit ratio is 14.3% (6/42). ~ the cluster with p-value < the hit ratio is 12.5% (2/16). 38
39 Results Drugs derived from ClusterONE (continued) Ø Hit ratios of three combinations >= 12.5%, which are higher than the 8.1% without using ClusterONE. Ø 8-azaguanine had been reported for four times (three combinations, and also reported without the use of ClusterONE. Ø Camptothecin and GW-8510 had been identified for three times. Ø Thioguanosine, verteporfin and azacitidine for two times. Ø Camptothecin, vorinostat and mitoxantrone showed a good IC50 in MTT assay (< 1 um). 39
40 Results Common drug targets Ø HRH1 and DNMT1 are targeted by cinnarizine and flucytosine, respectively. ~ HRH1 is a drug target recorded in both databases. Ø SCN9A, a target of lidocaine, was obtained from both databases. Ø DNMT1 is a down-regulated DEG; HRH1 and SCN9A are up-regulated DEGs. Ø HRH1, DNMT1 and SCN9A play important roles in the proliferation of VSMC associated diseases. Ø Drugs derived from ClusterONE ~ no drug target was found (very few DEGs) 40
41 Results Common drug targets (continued) Ø Table 5 summarized the results of the identified drug targets. Table 5. List of drug targets obtained from DrugBank and PubChem, and the common DEGs cmap Drug Target Gene from DrugBank Target Gene from NCBI PubChem DEG cinnarizine CACNA1C, CACNA1D, CACNA1F. CACNA1G, CACNA1H, CACNA1I, CACNA1S, DRD1, DRD2, DRD5, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1 ADRA2A, ADRA2B, ADRA2C, ADRA1D, CHRM1, CHRM3, CHRM4, CHRM5, DRD2, DRD3, HRH1, HTR2A, HTR2B, OPRM1, SLC6A4, SIGMAR1, SLC6A2. SLC6A3 HRH1 flucytosine DNMT1 Not available DNMT1 lidocaine SCN9A, SCN10A, EGFR SCN3A, SCN4A, SCN9A SCN9A 41
42 Results mirna-target interactions Ø mirtarbase and TarBase obtain mirna drug-target regulatory relations Ø Three mirna-regulated module are found (Fig.3). Ø Table 6 shows, mirnas target HRH1, DNMT1 and SCN9A, may resulted in the proliferation of VSMC associated diseases. 42
43 43
44 Results mirna target candidates for antimirs Ø We obtained one mirna - down-regulated drug target -regulated cluster. Ø These 17 mirnas represent a potential discovery of targets for developing antimirs (Table 6). a new therapeutic treatment concept the therapeutic potential of mirna regulation key candidate role for developing the mirna inhibitor. Ø AntimiRs as anti-disease drugs in treating CVDs. 44
45 Discussion and Conclusions Ø By processing the query gene sets with the ClusterONE, we achieved a higher hit ratio of drugs with measured IC50 activities. Ø Some of the identified drugs are under clinical trial testing. Ø Several mirna-regulated DEGs, whose mirnas are potential targets for developing antimir therapy. Ø The findings are supported by in vitro, clinical trial data and literature, shows the feasibility of the proposed approach. 45
46 Discussion and Conclusions Ø Deficiencies or limits as follows: 1. Using ClusterONE to improve drug prediction very few numbers of input genes no drug target was identified 2. we have not benchmarked the ClusterONE algorithm with other clustering algorithms. 3. The results are well supported; however, it is not certain whether the cmap drugs, tested for cancer cells, may be toxic to VSMC. 4. At the present time, the antimirs therapeutics have not yet been tested in a clinical setting. 46
47 Discussion and Conclusions Ø To examine how VSMC react in response to oxldl stimulation, a systematic study was proposed use time-course microarray data for identifying DEGs perform enrichment analysis for identifying the most relevant BP and pathway terms cmap was used to identify potential drugs use DrugBank and NCBI PubChem Compound to identify drug targets (DEGs) mirtarbase and TarBase were used to investigate mirna-target interactions, which regulated drug targets 47
48 Discussion and Conclusions Ø In conclusion, ~ Biological networks are composed of functional related modules, which play an essential role in many BPs (cooperative interaction and induce response). ~ potential drugs were identified, and certain drugs have been tested for effectiveness by in vitro anti-cvd effects and clinical trials ~ certain mirnas have been identified as targets for developing antimir and they may be used as an alternative therapeutic strategy for anti-cvd. 48
49 Discussion and Conclusions Ø Consequently, ~ The findings may be helpful in drug repurposing discovery and alternative therapeutic strategy. ~ Further studies are warranted to explore the effects of the potential drugs and antimirs for the proliferation of VSMC associated diseases 49
50 Acknowledgement Ø Ø Ø Ø Ø Professor Chien-Hung Huang, Department of Computer Engineering, National Formosa University, Taiwan. Professor Chi-Ying F Huang, Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taiwan. Professor Jeffrey J. P. Tsai and Victor C. Kok, Department of Bioinformatics and Medical Engineering, Asia University, Taiwan. Professor Nilubon Kurubanjerdjit, School of Information Technology, Mae Fah Luang University, Thailand. Ministry of Science and Technology of Taiwan (MOST) 50
51 51
DeSigN: connecting gene expression with therapeutics for drug repurposing and development. Bernard lee GIW 2016, Shanghai 8 October 2016
DeSigN: connecting gene expression with therapeutics for drug repurposing and development Bernard lee GIW 2016, Shanghai 8 October 2016 1 Motivation Average cost: USD 1.8 to 2.6 billion ~2% Attrition rate
More informationTranslational Bioinformatics: Connecting Genes with Drugs
Translational Bioinformatics: Connecting Genes with Drugs Aik Choon Tan, Ph.D. Associate Professor of Bioinformatics Division of Medical Oncology Department of Medicine aikchoon.tan@ucdenver.edu 11/14/2017
More informationIdentifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?
Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer
More informationGene-microRNA network module analysis for ovarian cancer
Gene-microRNA network module analysis for ovarian cancer Shuqin Zhang School of Mathematical Sciences Fudan University Oct. 4, 2016 Outline Introduction Materials and Methods Results Conclusions Introduction
More informationEXPression ANalyzer and DisplayER
EXPression ANalyzer and DisplayER Tom Hait Aviv Steiner Igor Ulitsky Chaim Linhart Amos Tanay Seagull Shavit Rani Elkon Adi Maron-Katz Dorit Sagir Eyal David Roded Sharan Israel Steinfeld Yossi Shiloh
More informationThe 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationAVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB
Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation
More informationSupplementary Figure 1. Metabolic landscape of cancer discovery pipeline. RNAseq raw counts data of cancer and healthy tissue samples were downloaded
Supplementary Figure 1. Metabolic landscape of cancer discovery pipeline. RNAseq raw counts data of cancer and healthy tissue samples were downloaded from TCGA and differentially expressed metabolic genes
More informationA General Workflow to Analyze Key Cancer-Related Genes Based on NCBI illustrated by the case of gastric cancer
A General Workflow to Analyze Key Cancer-Related Genes Based on NCBI illustrated by the case of gastric cancer Zhikuan Quan School of Statistics, Beijing Normal University, Beijing 100875, China 201511011114@bnu.edu.cn
More informationRASA: Robust Alternative Splicing Analysis for Human Transcriptome Arrays
Supplementary Materials RASA: Robust Alternative Splicing Analysis for Human Transcriptome Arrays Junhee Seok 1*, Weihong Xu 2, Ronald W. Davis 2, Wenzhong Xiao 2,3* 1 School of Electrical Engineering,
More informationSupporting Information
Supporting Information Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy Chi-Hsiu Liu 1, Zhongxiao Wang 1, Ye Sun 1, John Paul SanGiovanni 2, Jing Chen 1, * 1 Department
More informationNetwork-assisted data analysis
Network-assisted data analysis Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu Protein identification in shotgun proteomics Protein digestion LC-MS/MS Protein
More informationAutism Pathways Analysis: A Functional Framework and Clues for Further Investigation. Martha Herbert PhD MD Ya Wen PhD July 2016
Autism Pathways Analysis: A Functional Framework and Clues for Further Investigation Martha Herbert PhD MD Ya Wen PhD July 2016 1 Report on pathway network analyses in autism, based on open-access paper
More informationResults and Discussion of Receptor Tyrosine Kinase. Activation
Results and Discussion of Receptor Tyrosine Kinase Activation To demonstrate the contribution which RCytoscape s molecular maps can make to biological understanding via exploratory data analysis, we here
More informationCURRICULUM VITA OF Xiaowen Chen
Xiaowen Chen College of Bioinformatics Science and Technology Harbin Medical University Harbin, 150086, P. R. China Mobile Phone:+86 13263501862 E-mail: hrbmucxw@163.com Education Experience 2008-2011
More information38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16
38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16 PGAR: ASD Candidate Gene Prioritization System Using Expression Patterns Steven Cogill and Liangjiang Wang Department of Genetics and
More informationResearch Article Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
BioMed Research International, Article ID 193817, 13 pages http://dx.doi.org/10.1155/2014/193817 Research Article Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer Chien-Hung
More information15. Supplementary Figure 9. Predicted gene module expression changes at 24hpi during HIV
Supplementary Information Table of content 1. Supplementary Table 1. Summary of RNAseq data and mapping statistics 2. Supplementary Table 2. Biological functions enriched in 12 hpi DE genes, derived from
More informationNature Neuroscience: doi: /nn Supplementary Figure 1
Supplementary Figure 1 Illustration of the working of network-based SVM to confidently predict a new (and now confirmed) ASD gene. Gene CTNND2 s brain network neighborhood that enabled its prediction by
More informationDiscovery of Novel Human Gene Regulatory Modules from Gene Co-expression and
Discovery of Novel Human Gene Regulatory Modules from Gene Co-expression and Promoter Motif Analysis Shisong Ma 1,2*, Michael Snyder 3, and Savithramma P Dinesh-Kumar 2* 1 School of Life Sciences, University
More informationOn the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles
On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles Ying-Wooi Wan 1,2,4, Claire M. Mach 2,3, Genevera I. Allen 1,7,8, Matthew L. Anderson 2,4,5 *, Zhandong Liu 1,5,6,7 * 1 Departments of Pediatrics
More informationHao D. H., Ma W. G., Sheng Y. L., Zhang J. B., Jin Y. F., Yang H. Q., Li Z. G., Wang S. S., GONG Ming*
Comparison of transcriptomes and gene expression profiles of two chilling- and drought-tolerant and intolerant Nicotiana tabacum varieties under low temperature and drought stress Hao D. H., Ma W. G.,
More informationComparison of Triple Negative Breast Cancer between Asian and Western Data Sets
2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops Comparison of Triple Negative Breast Cancer between Asian and Western Data Sets Lee H. Chen Bioinformatics and Biostatistics
More informationOncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies
OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...
More informationMolecular BioSystems PAPER. Gene module based regulator inference identifying mir-139 as a tumor suppressor in colorectal cancer.
Molecular BioSystems PAPER Cite this: Mol. BioSyst., 2014, 10, 3249 Gene module based regulator inference identifying mir-139 as a tumor suppressor in colorectal cancer Jin Gu, * a Yang Chen, a Huiya Huang,
More informationCopyright 2015 American College of Cardiology Foundation
,,nn Wisløff, U., Bye, A., Stølen, T., Kemi, O. J., Pollott, G. E., Pande, M., McEachin, R. C., Britton, S. L., and Koch, L. G. (2015) Blunted cardiomyocyte remodeling response in exercise-resistant rats.
More informationmicrorna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease
microrna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease January 2018 Safe Harbor Statement Statements contained in this presentation regarding matters that are not
More informationDeconRNASeq: A Statistical Framework for Deconvolution of Heterogeneous Tissue Samples Based on mrna-seq data
DeconRNASeq: A Statistical Framework for Deconvolution of Heterogeneous Tissue Samples Based on mrna-seq data Ting Gong, Joseph D. Szustakowski April 30, 2018 1 Introduction Heterogeneous tissues are frequently
More informationNature Methods: doi: /nmeth.3115
Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by
More informationBootstrapped Integrative Hypothesis Test, COPD-Lung Cancer Differentiation, and Joint mirnas Biomarkers
Bootstrapped Integrative Hypothesis Test, COPD-Lung Cancer Differentiation, and Joint mirnas Biomarkers Kai-Ming Jiang 1,2, Bao-Liang Lu 1,2, and Lei Xu 1,2,3(&) 1 Department of Computer Science and Engineering,
More informationA two-step drug repositioning method based on a protein-protein interaction network of genes shared by two diseases and the similarity of drugs
www.bioinformation.net Hypothesis Volume 9(2) A two-step drug repositioning method based on a protein-protein interaction network of genes shared by two diseases and the similarity of drugs Yutaka Fukuoka*,
More informationInferring condition-specific mirna activity from matched mirna and mrna expression data
Inferring condition-specific mirna activity from matched mirna and mrna expression data Junpeng Zhang 1, Thuc Duy Le 2, Lin Liu 2, Bing Liu 3, Jianfeng He 4, Gregory J Goodall 5 and Jiuyong Li 2,* 1 Faculty
More informationfasting blood glucose [mg/dl]
SUPPLEMENTL MTERIL Supplemental Figure I body weight [g] 5 5 5 fasting blood glucose [mg/dl] 5 5 5 C total cholesterol [mg/dl] 8 6 4 WT Has -/- Supplemental Figure I: Has-deficient mice exhibited no apparent
More informationThe Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012
The Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012 Tracy Dixon-Salazar, Ph.D. University of California, San Diego American Epilepsy Society Annual Meeting 1 Disclosure
More informationDrug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory
Huang et al. BMC Bioinformatics 2016, 17(Suppl 1):2 DOI 10.1186/s12859-015-0845-0 PROCEEDINGS Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph
More informationa) List of KMTs targeted in the shrna screen. The official symbol, KMT designation,
Supplementary Information Supplementary Figures Supplementary Figure 1. a) List of KMTs targeted in the shrna screen. The official symbol, KMT designation, gene ID and specifities are provided. Those highlighted
More informationAccelerate Your Research with Conversant Bio
Imagination has given us the steam engine, the telephone, the talkingmachine and the automobile, for these things had to be dreamed of before they became realities. So I believe that dreams... are likely
More informationPatnaik SK, et al. MicroRNAs to accurately histotype NSCLC biopsies
Patnaik SK, et al. MicroRNAs to accurately histotype NSCLC biopsies. 2014. Supplemental Digital Content 1. Appendix 1. External data-sets used for associating microrna expression with lung squamous cell
More informationNew Enhancements: GWAS Workflows with SVS
New Enhancements: GWAS Workflows with SVS August 9 th, 2017 Gabe Rudy VP Product & Engineering 20 most promising Biotech Technology Providers Top 10 Analytics Solution Providers Hype Cycle for Life sciences
More informationTable S1. Quantitative RT-PCR primers
Table S1. Quantitative RT-PCR primers Gene Forward Primer Reverse Primer Human ApoB gcaagcagaagccagaagta ccatttggagaagcagtttgg Human ApoA1 gaaagctgcggtgctgac agtggccaggtccttcact Human MTP acggccattcccattgtg
More informationAward Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.
AD Award Number: W81XWH-08-1-0306 TITLE: Characterizing an EMT Signature in Breast Cancer PRINCIPAL INVESTIGATOR: Melanie C. Bocanegra CONTRACTING ORGANIZATION: Leland Stanford Junior University Stanford,
More informationEPIGENOMICS PROFILING SERVICES
EPIGENOMICS PROFILING SERVICES Chromatin analysis DNA methylation analysis RNA-seq analysis Diagenode helps you uncover the mysteries of epigenetics PAGE 3 Integrative epigenomics analysis DNA methylation
More informationMicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL
MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes
More informationIdentifying Potential Prognostic Biomarkers by Analyzing Gene Expression for Different Cancers
Identifying Potential Prognostic Biomarkers by Analyzing Gene Expression for Different Cancers Pragya Verma Department of Mathematics, Bioinformatics and Computer Applications Maulana Azad National Institute
More informationAbstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction
Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant
More informationIntegrative analysis of survival-associated gene sets in breast cancer
Varn et al. BMC Medical Genomics (2015) 8:11 DOI 10.1186/s12920-015-0086-0 RESEARCH ARTICLE Open Access Integrative analysis of survival-associated gene sets in breast cancer Frederick S Varn 1, Matthew
More informationEXTENDING ASSOCIATION RULE CHARACTERIZATION TECHNIQUES TO ASSESS THE RISK OF DIABETES MELLITUS
EXTENDING ASSOCIATION RULE CHARACTERIZATION TECHNIQUES TO ASSESS THE RISK OF DIABETES MELLITUS M.Lavanya 1, Mrs.P.M.Gomathi 2 Research Scholar, Head of the Department, P.K.R. College for Women, Gobi. Abstract
More informationDigitizing the Proteomes From Big Tissue Biobanks
Digitizing the Proteomes From Big Tissue Biobanks Analyzing 24 Proteomes Per Day by Microflow SWATH Acquisition and Spectronaut Pulsar Analysis Jan Muntel 1, Nick Morrice 2, Roland M. Bruderer 1, Lukas
More informationA quick review. The clustering problem: Hierarchical clustering algorithm: Many possible distance metrics K-mean clustering algorithm:
The clustering problem: partition genes into distinct sets with high homogeneity and high separation Hierarchical clustering algorithm: 1. Assign each object to a separate cluster. 2. Regroup the pair
More informationSupplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs.
Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs. (a) CNA analysis of expression microarray data obtained from 15 tumors in the SV40Tag
More informationLentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression.
Supplementary Figure 1 Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression. a, Design for lentiviral combinatorial mirna expression and sensor constructs.
More informationSUPPLEMENTARY APPENDIX
SUPPLEMENTARY APPENDIX 1) Supplemental Figure 1. Histopathologic Characteristics of the Tumors in the Discovery Cohort 2) Supplemental Figure 2. Incorporation of Normal Epidermal Melanocytic Signature
More informationCase Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD
Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review
More informationExpanded View Figures
Solip Park & Ben Lehner Epistasis is cancer type specific Molecular Systems Biology Expanded View Figures A B G C D E F H Figure EV1. Epistatic interactions detected in a pan-cancer analysis and saturation
More informationFacts from text: Automated gene annotation with ontologies and text-mining
1. Workshop des GI-Arbeitskreises Ontologien in Biomedizin und Lebenswissenschaften (OBML) Facts from text: Automated gene annotation with ontologies and text-mining Conrad Plake Schroeder Group (Bioinformatics),
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationA Network Partition Algorithm for Mining Gene Functional Modules of Colon Cancer from DNA Microarray Data
Method A Network Partition Algorithm for Mining Gene Functional Modules of Colon Cancer from DNA Microarray Data Xiao-Gang Ruan, Jin-Lian Wang*, and Jian-Geng Li Institute of Artificial Intelligence and
More informationExamination of Mechanisms of Hepatotoxicity of Anti-diabetic PPARγ Agonists Using Applied Biosystems Rat Whole Genome Microarrays
Examination of Mechanisms of Hepatotoxicity of Anti-diabetic PPARγ Agonists Using Applied Biosystems Rat Whole Genome Microarrays Lu Zhang b, Lei Guo a, Leming Shi a, Weida Tong a, Yongming Sun b, Gary
More informationNational Academies Next Generation SAMPLE Researchers TITLE Initiative HERE
National Academies Next Generation SAMPLE Researchers TITLE Initiative HERE Dennis A. Dean, II, PhD Sanofi Auditorium July 13, 2017 sevenbridges.com A little about me Research Experience Analytics and
More informationMicro-RNA web tools. Introduction. UBio Training Courses. mirnas, target prediction, biology. Gonzalo
Micro-RNA web tools UBio Training Courses Gonzalo Gómez//ggomez@cnio.es Introduction mirnas, target prediction, biology Experimental data Network Filtering Pathway interpretation mirs-pathways network
More informationRestoration. JDRF is turning Type One into Type None. attack so the newly restored beta cell function is protected.
Restoration JDRF is turning Type One into Type None Type 1 diabetes (T1D) is an extraordinarily complex disease. Finding the cure a short-term clinical intervention, with minimal side effects, after which
More informationmicrorna Presented for: Presented by: Date:
microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions
More informationResearch Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data
BioMed Research International, Article ID 459203, 15 pages http://dx.doi.org/10.1155/2014/459203 Research Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data
More informationNational Mesothelioma Virtual Bank 2017-Annual Face to Face Meeting ( Supported by CDC/NIOSH Grant U24OH009077
National Mesothelioma Virtual Bank 2017-Annual Face to Face Meeting (http://www.mesotissue.org) Supported by CDC/NIOSH Grant U24OH009077 Waqas Amin, MD Program Coordinator, NMVB Senior Research Scientist
More informationA Method to Determine an E-score Threshold to Identify Potential Cross Reactive Allergens
A Method to Determine an E-score Threshold to Identify Potential Cross Reactive Allergens Andre Silvanovich Ph. D. Gary Bannon Ph. D. Scott McClain Ph. D. Monsanto Company Regulatory Product Characterization
More informationFrom reference genes to global mean normalization
From reference genes to global mean normalization Jo Vandesompele professor, Ghent University co-founder and CEO, Biogazelle qpcr Symposium USA November 9, 2009 Millbrae, CA outline what is normalization
More informationIPA Advanced Training Course
IPA Advanced Training Course October 2013 Academia sinica Gene (Kuan Wen Chen) IPA Certified Analyst Agenda I. Data Upload and How to Run a Core Analysis II. Functional Interpretation in IPA Hands-on Exercises
More informationBig Image-Omics Data Analytics for Clinical Outcome Prediction
Big Image-Omics Data Analytics for Clinical Outcome Prediction Junzhou Huang, Ph.D. Associate Professor Dept. Computer Science & Engineering University of Texas at Arlington Dept. CSE, UT Arlington Scalable
More informationApplying Tissue Phenomics to Colorectal Clinical Questions
Applying Tissue Phenomics to Colorectal Clinical Questions International Symposium for Tissue Phenomics San Francisco October 2014 Peter Caie Senior Research Fellow University of St Andrews Systems Pathology
More informationFrom mirna regulation to mirna - TF co-regulation: computational
From mirna regulation to mirna - TF co-regulation: computational approaches and challenges 1,* Thuc Duy Le, 1 Lin Liu, 2 Junpeng Zhang, 3 Bing Liu, and 1,* Jiuyong Li 1 School of Information Technology
More informationComparison of Gene Set Analysis with Various Score Transformations to Test the Significance of Sets of Genes
Comparison of Gene Set Analysis with Various Score Transformations to Test the Significance of Sets of Genes Ivan Arreola and Dr. David Han Department of Management of Science and Statistics, University
More informationAVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationSupplementary data Comparison of transcriptomes of chilling- and drought-tolerant and intolerant Nicotiana tabacum
POJ 7(6):527-539(214) ISSN:1836-3644 Supplementary data Comparison of transcriptomes of chilling- and drought-tolerant and intolerant Nicotiana tabacum varieties and identification of genes associated
More informationAnalysis of paired mirna-mrna microarray expression data using a stepwise multiple linear regression model
Analysis of paired mirna-mrna microarray expression data using a stepwise multiple linear regression model Yiqian Zhou 1, Rehman Qureshi 2, and Ahmet Sacan 3 1 Pure Storage, 650 Castro Street, Suite #260,
More informationDepartment of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. 4
146 Journal of Atherosclerosis and Thrombosis Original Articles Vol. 11, No. 3 Clinical Features of Familial Hypercholesterolemia in Japan in a Database from 1996 1998 by the Research Committee of the
More informationA New Treatment Paradigm Outside-In
A New Treatment Paradigm Outside-In 2 2013 Mercator MedSystems OneMedForum Jan 8, 2013 Outside-In Response: Signal Amplification Signal convection Signal amplification Modified from Michel 2007, ATVB 3
More informationPlate-Based Assay Methods for the Assessment of Cellular Health
Plate-Based Assay Methods for the Assessment of Cellular Health Andrew L. Niles, Senior Research Scientist 2012, Promega Corporation. Biological Outcomes in Cell Culture Treatment -Small molecule -Bio-molecule
More informationSupplemental Information. A Highly Sensitive and Robust Method. for Genome-wide 5hmC Profiling. of Rare Cell Populations
Molecular ell, Volume 63 Supplemental Information Highly Sensitive and Robust Method for enome-wide hm Profiling of Rare ell Populations Dali Han, Xingyu Lu, lan H. Shih, Ji Nie, Qiancheng You, Meng Michelle
More informationGene Ontology and Functional Enrichment. Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein
Gene Ontology and Functional Enrichment Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein The parsimony principle: A quick review Find the tree that requires the fewest
More informationIdentification and Verification of Translational Biomarkers for Patient Stratification and Precision Medicine
Biomarkers for Patients Stratification and Precision Medicine -- Cancer and Beyond AAPS National Biotechnology Conference, Boston on May 16-18, 2016 Identification and Verification of Translational Biomarkers
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationmicrorna analysis Merete Molton Worren Ståle Nygård
microrna analysis Merete Molton Worren Ståle Nygård Help personnel: Daniel Vodak Background Dysregulation of mirna expression has been connected to progression and development of atherosclerosis The hypothesis:
More informationOA Biomarkers: What is required for validation and qualification? Part I. Evaluation Frameworks
OA Biomarkers: What is required for validation and qualification? Part I. Evaluation Frameworks Michael C. Nevitt, PhD Dept of Epidemiology and Biostatistics University of California, San Francisco OAI
More informationResearch Article RRHGE: A Novel Approach to Classify the Estrogen Receptor Based Breast Cancer Subtypes
e Scientific World Journal, Article ID 362141, 13 pages http://dx.doi.org/10.1155/2014/362141 Research Article RRHGE: A Novel Approach to Classify the Estrogen Receptor Based Breast Cancer Subtypes Ashish
More informationPredictive Assays in Radiation Therapy
Outline Predictive Assays in Radiation Therapy Radiation Biology Introduction Early predictive assays Recent trends in predictive assays Examples for specific tumors Summary Lecture 4-23-2014 Introduction
More informationDNA Microarray Analysis
DNA Microarray Analysis Course #27612 3-21 January 2011 DTU Center for Biological Sequence analysis (CBS) Teachers Carsten Friis Assistant professor Chemical Engineer and PhD from DTU Worked with bioinformatics
More informationTitle: Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Author's response to reviews Title: Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles Authors: Julia Tchou (julia.tchou@uphs.upenn.edu) Andrew V Kossenkov (akossenkov@wistar.org)
More informationcis-regulatory enrichment analysis in human, mouse and fly
cis-regulatory enrichment analysis in human, mouse and fly Zeynep Kalender Atak, PhD Laboratory of Computational Biology VIB-KU Leuven Center for Brain & Disease Research Laboratory of Computational Biology
More informationHigh AU content: a signature of upregulated mirna in cardiac diseases
https://helda.helsinki.fi High AU content: a signature of upregulated mirna in cardiac diseases Gupta, Richa 2010-09-20 Gupta, R, Soni, N, Patnaik, P, Sood, I, Singh, R, Rawal, K & Rani, V 2010, ' High
More informationInternational Space Station
NEWS News, features & press releases MISSIONS Current, future, past missions & launch dates MULTIMEDIA Images, videos, NASA TV & more CONNECT Social media channels & NASA apps ABOUT NASA Leadership, organization,
More informationAccessing and Using ENCODE Data Dr. Peggy J. Farnham
1 William M Keck Professor of Biochemistry Keck School of Medicine University of Southern California How many human genes are encoded in our 3x10 9 bp? C. elegans (worm) 959 cells and 1x10 8 bp 20,000
More informationUser Guide. Association analysis. Input
User Guide TFEA.ChIP is a tool to estimate transcription factor enrichment in a set of differentially expressed genes using data from ChIP-Seq experiments performed in different tissues and conditions.
More informationomiras: MicroRNA regulation of gene expression
omiras: MicroRNA regulation of gene expression Sören Müller, Goethe University of Frankfurt am Main Molecular Bioinformatics Group, Institute of Computer Science Plant Molecular Biology Group, Institute
More informationBowel Disease Research Foundation
Research Project Annual Report Lead investigator Dr Ricky Sharma Institution Department of Oncology, University of Oxford Project Title Making radiotherapy for rectal cancer more effective by identifying
More informationPCxN: The pathway co-activity map: a resource for the unification of functional biology
PCxN: The pathway co-activity map: a resource for the unification of functional biology Sheffield Institute for Translational Neurosciences Center for Integrative Genome Translation GENOME INFORMATICS
More informationIntegrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers
Integrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers Songjian Lu, PhD, Xinghua Lu, MD. PhD Dept. Biomedical Informatics, Univ. Pittsburgh, PA 15232
More informationPredicting Heart Attack using Fuzzy C Means Clustering Algorithm
Predicting Heart Attack using Fuzzy C Means Clustering Algorithm Dr. G. Rasitha Banu MCA., M.Phil., Ph.D., Assistant Professor,Dept of HIM&HIT,Jazan University, Jazan, Saudi Arabia. J.H.BOUSAL JAMALA MCA.,M.Phil.,
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10866 a b 1 2 3 4 5 6 7 Match No Match 1 2 3 4 5 6 7 Turcan et al. Supplementary Fig.1 Concepts mapping H3K27 targets in EF CBX8 targets in EF H3K27 targets in ES SUZ12 targets in ES
More informationchapter 1 - fig. 2 Mechanism of transcriptional control by ppar agonists.
chapter 1 - fig. 1 The -omics subdisciplines. chapter 1 - fig. 2 Mechanism of transcriptional control by ppar agonists. 201 figures chapter 1 chapter 2 - fig. 1 Schematic overview of the different steps
More information